LawPlayer
My bookmarks
Source

Commission Implementing Decision (EU) 2025/439 of 28 February 2025 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council (notified under document C(2025) 1244)

Commission Implementing Decision (EU) 2025/439 of 28 February 2025 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council (notified under document C(2025) 1244)

Implementing Decision (EU) 2025/439 · Decision · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The watch list of substances for Union-wide monitoring referred to in Article 8b of Directive 2008/105/EC is set out in the Annex to this Decision.

Supplementary provisions

Watch list of substances for Union-wide monitoring as set out in Article 8b of Directive 2008/105/EC

ANNEXSupplementary provisions

Open ↗

ANNEX Watch list of substances for Union-wide monitoring as set out in Article 8b of Directive 2008/105/EC Name of substance/group of substances Chemical Abstracts Service (CAS) number European Community (EC) number  ( 1 ) Indicative analytical method  ( 2 ) ,  ( 3 ) Maximum acceptable method quantification limit (ng/l) Fipronil 120068-37-3 424-610-5 SPE-HPLC-MS/MS 0,77 Clindamycin 18323-44-9 242-209-1 SPE-LC-MS/MS 44 Ofloxacin 82419-36-1 680-263-1 SPE-UHPLC-MS/MS 26 Metformin and Guanylurea  ( 4 ) 657-24-9 141-83-3 211-517-8 205-504-6 SPE-LC-MS/MS 156 000 100 000 Sunscreen agents  ( 5 ) Butyl methoxydibenzoyl-methane Octocrylene Benzophenone-3 Octisalate (2-ethylhexyl salicylate) 70356-09-1 6197-30-4 131-57-7 118-60-5 274-581-6 228-250-8 205-031-5 204-263-4 SPE-LC-ESI-MS/MS 3 000 266 670 168 N-1,3-Dimethylbutyl-N’-phenyl-p-phenylenediamine (6PPD) and 6PPD-quinone  ( 6 ) 793-24-8 2754428-18-5 212-344-0 893-269-6 SPE-LC-MS/MS 370 Abamectin  ( 7 ) Avermectin B1a and Avermectin B1b 71751-41-2 65195-55-3 65195-56-4 265-610-3 265-611-9 SPE-LC-MS/MS 1 Azole compounds  ( 8 ) Bromuconazole Climbazole Cyazofamid Difenoconazole Epoxiconazole Itraconazole Ketoconazole Mefentrifluconazole Propiconazole Triticonazole 116255-48-2 38083-17-9 120116-88-3 119446-68-3 133855-98-8 84625-61-6 65277-42-1 1417782-03-6 60207-90-1 131983-72-7 408-060-3 253-775-4 601-671-8 601-613-1 406-850-2 617-596-9 265-667-4 822-682-6 262-104-4 603-543-7 SPE-LC-MS/MS 15 110 130 360 180 8 50 1 600 1 000 1 000 Etoxazole 153233-91-1 604-891-2 SPE-GC-MS/MS 0,4 Fluoxetine 54910-89-3 611-209-7 SPE-LC-QTOF-HRMS 12 Propranolol 525-66-6 208-378-0 SPE-LC-MS/MS 20 Oxytetracycline and Tetracycline  ( 9 ) 79-57-2 60-54-8 201-212-8 200-481-9 SPE-LC-MS/MS 500 90 ( 1 )   Not available for all substances ( 2 )   All substances shall be monitored in whole water samples. ( 3 )   Extraction methods: SPE – solid-phase extraction Analytical methods: HPLC-MS/MS– High-performance liquid chromatography (tandem) triple quadrupole mass spectrometry LC-MS/MS – Liquid chromatography (tandem) triple quadrupole mass spectrometry LC-ESI-MS/MS – Liquid chromatography (tandem) triple quadrupole mass spectrometry with positive electrospray ionisation LC-QTOF-HRMS – Liquid chromatography quadrupole time-of-flight high-resolution mass spectrometry UHPLC-MS/MS – Ultra-high-performance liquid chromatography (tandem) triple quadrupole mass spectrometry ( 4 )   Metformin and guanylurea shall be analysed together in the same samples but reported as individual concentrations. ( 5 )   The sunscreen agents shall be analysed together in the same samples but reported as individual concentrations. ( 6 )   6PPD and 6PPD-quinone shall be analysed together in the same samples but reported as individual concentrations ( 7 )   The two major components of abamectin (B1a and B1b) shall be analysed together in the same samples and reported as a sum concentration. ( 8 )   The azole compounds shall be analysed together in the same samples but reported as individual concentrations. ( 9 )   Oxytetracycline and tetracycline shall be analysed together in the same samples but reported as individual concentrations.

Other acts of the same type
Commission Implementing Decision (EU) 2022/2277 of 15 November 2022 accepting a request submitted by the Italian Republic pursuant to Article 7(4) of Directive (EU) 2016/797 of the European Parliament and of the Council not to apply point 4.2.1.5.2, (b)(1) of the Annex to Commission Regulation (EU) No 1303/2014 (notified under document C(2022) 8068) (Only the Italian text is authentic)Council Decision (CFSP) 2022/2232 of 14 November 2022 amending Decision (CFSP) 2018/1544 concerning restrictive measures against the proliferation and use of chemical weaponsCouncil Decision (CFSP) 2022/2233 of 14 November 2022 amending Decision 2014/145/CFSP concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCouncil Implementing Decision (CFSP) 2022/2234 of 14 November 2022 implementing Decision 2011/235/CFSP concerning restrictive measures directed against certain persons and entities in view of the situation in IranCouncil Implementing Decision (CFSP) 2022/2235 of 14 November 2022 implementing Decision 2011/235/CFSP concerning restrictive measures directed against certain persons and entities in view of the situation in IranCouncil Decision (CFSP) 2022/2241 of 14 November 2022 amending Decision 2010/788/CFSP concerning restrictive measures in view of the situation in the Democratic Republic of the CongoCouncil Decision (EU) 2022/2242 of 14 November 2022 on the financial contributions to be paid by the parties to the European Development Fund to finance that fund, specifying the ceiling for 2024, the annual amount for 2023, the amount of the first instalment for 2023 and an indicative and non-binding forecast for the expected annual amounts of contributions for the years 2025 and 2026Council Decision (CFSP) 2022/2243 of 14 November 2022 launching the European Union Military Assistance Mission in support of Ukraine (EUMAM Ukraine)Council Decision (CFSP) 2022/2244 of 14 November 2022 on the participation of the United Kingdom of Great Britain and Northern Ireland in the PESCO project Military MobilityCouncil Decision (CFSP) 2022/2245 of 14 November 2022 on an assistance measure under the European Peace Facility to support the Ukrainian Armed Forces trained by the European Union Military Assistance Mission in support of Ukraine with military equipment, and platforms, designed to deliver lethal forceCouncil Decision (EU) 2022/2248 of 14 November 2022 appointing a member of the Court of AuditorsCouncil Decision (EU) 2022/2488 of 14 November 2022 establishing the position to be taken on behalf of the European Union within the International Sugar Council concerning the accession of the Kingdom of Saudi Arabia to the International Sugar Agreement, 1992

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next